Dihydroergotamine Mesylate and Lithium Citrate Syrup
Determining the interaction of Dihydroergotamine Mesylate and Lithium Citrate Syrup and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Lithium Controlled-Release and Extended-Release Tablets
- Dihydroergotamine Mesylate-Lithium ER
- Dihydroergotamine Mesylate-Lithium Oral Solution
- Dihydroergotamine Mesylate-Lithium Salts
- Dihydroergotamine Mesylate-Lithium Syrup and Oral Solution
- Dihydroergotamine Mesylate-Lithobid
- Lithium Citrate Syrup-Dihydroergotamine nasal
- Lithium Citrate Syrup-Dihydroergotamine Nasal Spray
- Lithium Citrate Syrup-Dilacor XR
- Lithium Citrate Syrup-Dilantin
- Lithium Citrate Syrup-Dilantin Infatabs
- Lithium Citrate Syrup-Dilantin injection